Prevalence of polycystic ovary syndrome among premenopausal women with type 2 diabetes

被引:81
作者
Peppard, HR
Iuorno, MJ
Marfori, J
Nestler, JE
机构
[1] Virginia Commonwealth Univ, Med Coll Virginia, Dept Internal Med, Div Endocrinol & Metab, Richmond, VA 23298 USA
[2] Virginia Commonwealth Univ, Med Coll Virginia, Dept Obstet & Gynecol, Richmond, VA 23298 USA
关键词
D O I
10.2337/diacare.24.6.1050
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
OBJECTIVE - Women with polycystic ovary syndrome (PCOS) have an increased risk for developing type 2 diabetes. Few studies have assessed women with type 2 diabetes to determine the frequency of PCOS in this population. RESEARCH DESIGN AND METHODS - To determine the prevalence of PCOS- among premenopausal women with type 2 diabetes, we conducted a retrospective cross- sectional prevalence study. We reviewed the medical records of all women seen in the Diabetes Clinic of the Medical College of Virginia Hospitals between January 1995 through February 2000. A diagnosis of PCOS was based on 1) oligomenorrhea, 2) hyperandrogenism (biochemical or clinical), and 3) exclusion of other related disorders. RESULTS - We reviewed the medical records of 618 women with diabetes and identified 47 women eligible for study. Of the 47 women, 30 consented to an evaluation. Of the 30 women evaluated, 8 were identified as having PCOS (6 women reported a previous PCOS diagnosis and 2 women were neu ly diagnosed), resulting in a prevalence of 26.7%. CONCLUSIONS - We concluded that PCOS occurs frequently among premenopausal women with type 2 diabetes.
引用
收藏
页码:1050 / 1052
页数:3
相关论文
共 14 条
[1]  
ACHARD MC, 1921, B ACAD NATL MED, V86, P51
[2]  
AZZIZ R, 1997, ANDROGEN EXCESS DISO, V1
[3]   The prevalence of polycystic ovaries in women with type 2 diabetes mellitus [J].
Conn, JJ ;
Jacobs, HS ;
Conway, GS .
CLINICAL ENDOCRINOLOGY, 2000, 52 (01) :81-86
[4]   PROFOUND PERIPHERAL INSULIN RESISTANCE, INDEPENDENT OF OBESITY, IN POLYCYSTIC OVARY SYNDROME [J].
DUNAIF, A ;
SEGAL, KR ;
FUTTERWEIT, W ;
DOBRJANSKY, A .
DIABETES, 1989, 38 (09) :1165-1174
[5]   Prevalence of impaired glucose tolerance and diabetes in women with polycystic ovary syndrome [J].
Ehrmann, DA ;
Barnes, RB ;
Rosenfield, RL ;
Cavaghan, MK ;
Imperial, J .
DIABETES CARE, 1999, 22 (01) :141-146
[6]   Effect of troglitazone on endocrine and ovulatory performance in women with insulin resistance-related polycystic ovary syndrome [J].
Hasegawa, I ;
Murakawa, H ;
Suzuki, M ;
Yamamoto, Y ;
Kurabayashi, T ;
Tanaka, K .
FERTILITY AND STERILITY, 1999, 71 (02) :323-327
[7]   HIRSUTISM - IMPLICATIONS, ETIOLOGY, AND MANAGEMENT [J].
HATCH, R ;
ROSENFIELD, RL ;
KIM, MH ;
TREDWAY, D .
AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 1981, 140 (07) :815-830
[8]   Prevalence of the polycystic ovary syndrome in unselected black and white women of the southeastern United States: A prospective study [J].
Knochenhauer, ES ;
Key, TJ ;
Kahsar-Miller, M ;
Waggoner, W ;
Boots, LR ;
Azziz, R .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1998, 83 (09) :3078-3082
[9]   Prevalence and predictors of risk for type 2 diabetes mellitus and impaired glucose tolerance in polycystic ovary syndrome: A prospective, controlled study in 254 affected women [J].
Legro, RS ;
Kunselman, AR ;
Dodson, WC ;
Dunaif, A .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1999, 84 (01) :165-169
[10]   Metformin effects on clinical features, endocrine and metabolic profiles, and insulin sensitivity in polycystic ovary syndrome: A randomized, double-blind, placebo-controlled 6-month trial, followed by open, long-term clinical evaluation [J].
Moghetti, P ;
Castello, R ;
Negri, C ;
Tosi, F ;
Perrone, F ;
Caputo, M ;
Zanolin, E ;
Muggeo, M .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2000, 85 (01) :139-146